Literature DB >> 29296451

SBRT treatment of multiple extracranial oligometastases using a single isocenter with distinct optimizations.

Michael Trager1, Joseph Salama2, Fang-Fang Yin2, Justus Adamson2.   

Abstract

PURPOSE: We address the challenges associated with applying a single isocenter treatment technique to extracranial oligometastases.
METHODS: We propose a technique that uses a Single Isocenter with Distinct Optimizations (SIDO) in which all Volumetric Modulated Arc Therapy (VMAT) fields share an isocenter but each field treats only one target. When necessary, setup uncertainties from rotations and deformations are mitigated by applying a couch translation between VMAT arcs, and interplay is minimized using dynamic conformal arcs (DCA) as the starting point for inverse optimization. Using CBCTs from eleven previous SBRT cases we determined the likelihood of needing a translational shift between SIDO arcs to correct rotational uncertainties. We also compared SIDO and SIDO with DCA to single (VMAT) and dual (VMAT and DCA) isocenter plans for phantom (N=11) and patient (N=4) cases.
RESULTS: Spatial uncertainties from inter-fractional rotations were greatest for large target separation and small margins, with ~30% of fractions requiring a correction (3mm margin and 10cm separation). SIDO with DCA greatly decreased arc modulation, with approximately 20% more modulation than DCA, and similar conformity to conventional VMAT. SIDO and SIDO with DCA had comparable conformity to single and dual isocenter plans when separation between PTVs is >3cm, while traditional single isocenter VMAT had superior conformity for <3cm. SIDO with DCA had superior GI over other planning techniques for almost all cases.
CONCLUSION: SIDO for extracranial oligometastases allows flexibility to mitigate spatial uncertainties from rotation and deformation, and has comparable dosimetry to traditional VMAT with low modulation when inverse optimization begins with DCA.

Entities:  

Keywords:  Oligometastases; SBRT; SIDO; VMAT; multifocal; single isocenter

Year:  2017        PMID: 29296451      PMCID: PMC5658822     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  18 in total

1.  Single-isocenter frameless intensity-modulated stereotactic radiosurgery for simultaneous treatment of multiple brain metastases: clinical experience.

Authors:  Sameer K Nath; Joshua D Lawson; Daniel R Simpson; Lauren Vanderspek; Jia-Zhu Wang; John F Alksne; Joseph Ciacci; Arno J Mundt; Kevin T Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-22       Impact factor: 7.038

2.  Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].

Authors:  Min Rao; Jianzhou Wu; Daliang Cao; Tony Wong; Vivek Mehta; David Shepard; Jinsong Ye
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-24       Impact factor: 7.038

Review 3.  Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy.

Authors:  Kimberly S Corbin; Samuel Hellman; Ralph R Weichselbaum
Journal:  J Clin Oncol       Date:  2013-03-04       Impact factor: 44.544

4.  Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer.

Authors:  Atsuya Takeda; Etsuo Kunieda; Toshio Ohashi; Yousuke Aoki; Naoyoshi Koike; Toshiaki Takeda
Journal:  Radiother Oncol       Date:  2011-11       Impact factor: 6.280

5.  Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments.

Authors:  Cassandra Stambaugh; Benjamin E Nelms; Thomas Dilling; Craig Stevens; Kujtim Latifi; Geoffrey Zhang; Eduardo Moros; Vladimir Feygelman
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

6.  Plan quality and treatment planning technique for single isocenter cranial radiosurgery with volumetric modulated arc therapy.

Authors:  Grant M Clark; Richard A Popple; Brendan M Prendergast; Sharon A Spencer; Evan M Thomas; John G Stewart; Barton L Guthrie; James M Markert; John B Fiveash
Journal:  Pract Radiat Oncol       Date:  2012-01-30

7.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Authors:  Michael T Milano; Alan W Katz; Hong Zhang; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-13       Impact factor: 7.038

8.  Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of multiple brain metastases.

Authors:  Grant M Clark; Richard A Popple; P Edward Young; John B Fiveash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

9.  Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy.

Authors:  Chin Loon Ong; Max Dahele; Ben J Slotman; Wilko F A R Verbakel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-15       Impact factor: 7.038

10.  Stereotactic body radiotherapy for oligometastatic lung tumors.

Authors:  Yoshiki Norihisa; Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Takashi Sakamoto; Masato Sakamoto; Takashi Mizowaki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

View more
  3 in total

1.  Improving treatment efficiency via photon optimizer (PO) MLC algorithm for synchronous single-isocenter/multiple-lesions VMAT lung SBRT.

Authors:  Lana Sanford; Damodar Pokhrel
Journal:  J Appl Clin Med Phys       Date:  2019-09-20       Impact factor: 2.102

2.  Risk of target coverage loss for stereotactic body radiotherapy treatment of synchronous lung lesions via single-isocenter volumetric modulated arc therapy.

Authors:  Lana C Critchfield; Mark E Bernard; Marcus E Randall; Ronald C McGarry; Damodar Pokhrel
Journal:  J Appl Clin Med Phys       Date:  2020-12-20       Impact factor: 2.102

3.  Automation and integration of a novel restricted single-isocenter stereotactic body radiotherapy (a-RESIST) method for synchronous two lung lesions.

Authors:  Lana Sanford Critchfield; Justin Visak; Mark E Bernard; Marcus E Randall; Ronald C McGarry; Damodar Pokhrel
Journal:  J Appl Clin Med Phys       Date:  2021-05-25       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.